Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Advanced Life Sciences Holdings, Inc.
Advanced Life Sciences Regains Compliance With Nasdaq Listing Requirements
May 2nd, 2008
Advanced Life Sciences Holdings, Inc. (NASDAQ:ADLS), announced that it has regained compliance with the Nasdaq Capital Market listing requirements. On April 16, 2008, the Company received notification from the Nasdaq Listing Qualification Department that it has regained compliance with Nasdaq Marketplace Rule 4310(c)(4) because the closing bid price of the Company's common stock has been equal to or in excess of $1.00 for a minimum of ten consecutive business days. About Advanced Life Sciences Advanced Life Sciences is a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of...
Source: Health Business Week (2008-05-02)
|
